Abbondanzo SJ, Chang SL (2014) HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging. PLoS ONE 9:e105256. https://doi.org/10.1371/journal.pone.0105256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ait-Ammar A, Kula A, Darcis G, Verdikt R, De Wit S, Gautier V, Mallon PWG, Marcello A, Rohr O, Van Lint C (2020) Current status of latency reversing agents facing the heterogeneity of HIV_1 cellular and tissue reservoirs. Front Microbiol 10:3060. https://doi.org/10.3389/fmicb.2019.03060

Article  PubMed  PubMed Central  Google Scholar 

Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V (2019) HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc 8:e012241. https://doi.org/10.1161/JAHA.119.012241

Article  PubMed  PubMed Central  Google Scholar 

Bhowmik R, Chaubey B (2022) CRISPR/Cas9: a tool to eradicate HIV-1. AIDS Res Ther 19:58. https://doi.org/10.1186/s12981-022-00483-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohlen CJ, Bennett FC, Tucker AF, Collins HY, Mulinyawe SB, Barres BA (2017) Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures. Neuron 94:759–773e8. https://doi.org/10.1016/j.neuron.2017.04.043

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caldeira C, Oliveira AF, Cunha C, Vaz AR, Falcão, Fernandes A, Brites D (2014) Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci 8:152. https://doi.org/10.3389/fncel.2014.00152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 94:13193–13197. https://doi.org/10.1073/pnas.94.24.13193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R (2016) HIV reservoirs: what, where and how to target them. Nat Rev Microbiol 14:55–60. https://doi.org/10.1038/nrmicro.2015.5

Article  CAS  PubMed  Google Scholar 

Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823. https://doi.org/10.1126/science.1231143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cristóvão AC, Saavedra A, Fonseca CP, Campos F, Duarte EP, Baltazar G (2010) Microglia of rat ventral midbrain recovers is resting state over time in vitro: let microglia rest before work. J Neurosci Res 88:552–562. https://doi.org/10.1002/jnr.22219

Article  CAS  PubMed  Google Scholar 

Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10:350–357. https://doi.org/10.1080/13550280490521078

Article  PubMed  Google Scholar 

Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE (2019) Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 10:2753. https://doi.org/10.1038/s41467-019-10366-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denaro F, Benedetti F, Worthington MD, Scapagnini G, Krauss CC, Williams S, Bryant J, Davis H, Latinovic OS, Zella D (2020) The HIV-1 transgenic rat: relevance for HIV noninfectious comorbidity research. Microorganisms 8:1643. https://doi.org/10.3390/microorganisms8111643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denenberg VH (1984) Some statistical and experimental considerations in the use of the analysis-of-variance procedure. Am J Physiol 246:R403–R408. https://doi.org/10.1152/ajpregu.1984.246.4.R403

Article  CAS  PubMed  Google Scholar 

Ebina H, Misawa N, Kanemura Y, Koyanagi Y (2013) Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3:2510. https://doi.org/10.1038/srep02510

Article  PubMed  PubMed Central  Google Scholar 

Eisele E, Siliciano RF (2012) Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37:377–388. https://doi.org/10.1016/j.immuni.2012.08.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295–1300. https://doi.org/10.1126/science.278.5341.1295

Article  CAS  PubMed  Google Scholar 

Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59–65. https://doi.org/10.1038/nbt.1515

Article  CAS  PubMed  Google Scholar 

Fuster JM (2008) The prefrontal cortex, 4 edn. Academic Press, London

Google Scholar 

Gama L, Abreu CM, Shirk EN, Price SL, Li M, Laird GM, Metcalf Pate KA, Wietgrefe SW, O’Connor SL, Pianowski L, Haase AT, Van Lint C, Siliciano RF, Clements JE, LRA-SIV Study Group (2017) Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS 31:5–14. https://doi.org/10.1097/QAD.0000000000001267

Article  CAS  PubMed  Google Scholar 

Gantner P, Buranapraditkun S, Pagliuzza A, Dufour C, Pardons M, Mitchell JL, Kroon E, Sacdalan C, Tulmethakaan N, Pinyakorn S, Robb ML, Phanuphak N, Ananworanich J, Hsu D, Vasan S, Trautmann L, Fromentin R, Chomont N (2023) HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections. Immunity 56:653–668e5. https://doi.org/10.1016/j.immuni.2023.01.030

Article  CAS  PubMed  Google Scholar 

Garvey LJ, Yerrakalva D, Winston A (2009) Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retrovir 25(8):765–769. https://doi.org/10.1089/aid.2008.0292

Article  PubMed  Google Scholar 

Gasiunas G, Barrangou R, Horvath P, Siksnys V (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 109:E2579–2586. https://doi.org/10.1073/pnas.1208507109

Article  PubMed  PubMed Central  Google Scholar 

Geng G, Liu B, Chen C, Wu K, Liu J, Zhang Y, Pan T, Li J, Yin Y, Zhang J, Huang F, Yu F, Chen J, Ma X, Zhou J, Kuang E, Liu C, Cai W, Zhang H (2016) Development of an attenuated Tat protein as a highly-effective agent to specifically activate HIV-1 latency. Mol Ther 24:1528–1537. https://doi.org/10.1038/mt.2016.117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, Jaeger BN, O’Connor C, Fitzpatrick C, Pasillas MP, Pena M, Adair A, Gonda DD, Levy ML, Ransohoff RM, Gage FH, Glass CK (2017) An environment-dependent transcriptional network specifies human microglia identity. Science 356:eaal3222. https://doi.org/10.1126/science.aal3222

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS ONE 12:e0171887. https://doi.org/10.1371/journal.pone.0171887

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19:1058–1069. https://doi.org/10.1038/mt.2011.72

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruell H, Gunst JD, Cohen YZ, Pahus MH, Malin JJ, Platten M, Millard KG, Tolstrup M, Jones RB, Conce Alberto WD, Lorenzi JCC, Oliveira TY, Kümmerle T, Suárez I, Unson-O’Brien C, Nogueira L, Olesen R, Østergaard L, Nielsen H, Lehmann C, Nussenzweig MC, Fätkenheuer G, Klein F, Caskey M, Søgaard OS (2022) Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial. Lancet Microbe 3:e203–e214. https://doi.org/10.1016/S2666-5247(21)00239-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruntman AM, Su L, Flotte TR (2017) Retro-orbital venous sinus delivery of rAAV9 mediates high-level transduction of brain and retina compared with temporal vein delivery in neonatal mouse pups. Hum Gene Ther 28:228–230. https://doi.org/10.1089/hum.2017.037

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA (1997) Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 337:734–739. https://doi.org/10.1056/NEJM199709113371102

Article